ECS Botanics Holdings entered into a 3-year binding agreement

ECS Botanics Holdings Ltd (ASX: ECS) announced that it had signed a 3-year binding contract with German company Ilios Santé GmbH to deliver medicinal cannabis products. This agreement would help the company to generate a minimum of AU$9.9 million in revenue.

Under the agreement, the company will exclusively deliver four medicinal cannabis strains to Ilios Sante with a minimum revenue of AU$9.9 million of GMP-manufactured medicinal cannabis products over three years. As per the conditions of the agreement, both parties may dismiss the contract within ten days before notice if either party breaks any terms and conditions of the agreement or is unable to establish or maintain industry quality standards and fails to correct within 30 days.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com